Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer.
Garrido-Laguna I; Tan AC; Uson M; Angenendt M; Ma WW; Villaroel MC; Zhao M; Rajeshkumar NV; Jimeno A; Donehower R; Iacobuzio-Donahue C; Barrett M; Rudek MA; Rubio-Viqueira B; Laheru D; Hidalgo M; British Journal Of Cancer, 2010, vol. 103, issue 5, p 649, ISSN 15321827. ISBN 15321827.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef